HK1131140A1 - Substituted prolinamides, and the use thereof - Google Patents

Substituted prolinamides, and the use thereof

Info

Publication number
HK1131140A1
HK1131140A1 HK09110801.9A HK09110801A HK1131140A1 HK 1131140 A1 HK1131140 A1 HK 1131140A1 HK 09110801 A HK09110801 A HK 09110801A HK 1131140 A1 HK1131140 A1 HK 1131140A1
Authority
HK
Hong Kong
Prior art keywords
prolinamides
substituted
substituted prolinamides
Prior art date
Application number
HK09110801.9A
Other languages
English (en)
Chinese (zh)
Inventor
Kai Gerlach
Henning Priepke
Roland Pfau
Wolfgang Wienen
Annette Schuler-Metz
Georg Dahmann
Herbert Nar
Original Assignee
貝林格爾．英格海姆國際有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 貝林格爾．英格海姆國際有限公司 filed Critical 貝林格爾．英格海姆國際有限公司
Publication of HK1131140A1 publication Critical patent/HK1131140A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
HK09110801.9A 2006-05-16 2009-11-19 Substituted prolinamides, and the use thereof HK1131140A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06113977 2006-05-16
EP07102566 2007-02-16
PCT/EP2007/054631 WO2007131982A2 (de) 2006-05-16 2007-05-14 Substituierte prolinamide, deren herstellung und deren verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
HK1131140A1 true HK1131140A1 (en) 2010-01-15

Family

ID=38646563

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09110801.9A HK1131140A1 (en) 2006-05-16 2009-11-19 Substituted prolinamides, and the use thereof

Country Status (24)

Country Link
US (1) US7807693B2 (ko)
EP (1) EP2051975B1 (ko)
JP (1) JP5263686B2 (ko)
KR (1) KR101422456B1 (ko)
AR (1) AR060945A1 (ko)
AU (1) AU2007251614B2 (ko)
BR (1) BRPI0711648A2 (ko)
CA (1) CA2653753C (ko)
CL (1) CL2007001391A1 (ko)
DK (1) DK2051975T3 (ko)
EA (1) EA200802210A1 (ko)
EC (1) ECSP088824A (ko)
ES (1) ES2395538T3 (ko)
HK (1) HK1131140A1 (ko)
IL (1) IL195245A (ko)
MX (1) MX2008014499A (ko)
MY (1) MY146623A (ko)
NO (1) NO20084530L (ko)
NZ (1) NZ573573A (ko)
PE (1) PE20080702A1 (ko)
PL (1) PL2051975T3 (ko)
TW (1) TW200813047A (ko)
UY (1) UY30352A1 (ko)
WO (1) WO2007131982A2 (ko)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1975165A1 (de) 2007-03-27 2008-10-01 Boehringer Ingelheim Pharma GmbH & Co. KG Substituierte Pyrrolidinamide, deren Herstellung und deren Verwendung als Arzneimittel
WO2009063028A2 (en) 2007-11-15 2009-05-22 Boehringer Ingelheim International Gmbh Substituted amides, manufacturing and use thereof as medicaments
JP2011518127A (ja) * 2008-03-31 2011-06-23 エヴォテック・アクチエンゲゼルシャフト ヒスタミンｈ３受容体アンタゴニストとしてのテトラヒドロナフチリジンおよびそれらのアザ誘導体
GB201209138D0 (en) * 2012-05-24 2012-07-04 Ono Pharmaceutical Co Compounds
WO2014127815A1 (en) 2013-02-21 2014-08-28 Boehringer Ingelheim International Gmbh Dihydropteridinones i
JP6337750B2 (ja) * 2013-11-22 2018-06-06 小野薬品工業株式会社 化合物
SG11201606080SA (en) 2014-02-03 2016-08-30 Vitae Pharmaceuticals Inc Dihydropyrrolopyridine inhibitors of ror-gamma
SG11201607267SA (en) * 2014-03-07 2016-09-29 Biocryst Pharm Inc Human plasma kallikrein inhibitors
HUE042335T2 (hu) 2014-10-14 2019-06-28 Vitae Pharmaceuticals Inc ROR-gamma dihidropirrolopiridin inhibitorai
US9663515B2 (en) 2014-11-05 2017-05-30 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
US9845308B2 (en) 2014-11-05 2017-12-19 Vitae Pharmaceuticals, Inc. Isoindoline inhibitors of ROR-gamma
EP3078378B1 (en) 2015-04-08 2020-06-24 Vaiomer Use of factor xa inhibitors for regulating glycemia
EP3331876B1 (en) 2015-08-05 2020-10-07 Vitae Pharmaceuticals, LLC Modulators of ror-gamma
EP3377482B1 (en) 2015-11-20 2021-05-12 Vitae Pharmaceuticals, LLC Modulators of ror-gamma
TWI757266B (zh) 2016-01-29 2022-03-11 美商維它藥物有限責任公司 ＲＯＲ－γ調節劑
US9481674B1 (en) 2016-06-10 2016-11-01 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
MX2020000887A (es) 2017-07-24 2020-07-22 Vitae Pharmaceuticals Llc Inhibidores de ror?.
WO2019018975A1 (en) 2017-07-24 2019-01-31 Vitae Pharmaceuticals, Inc. INHIBITORS OF ROR GAMMA
CN114646701B (zh) * 2022-03-01 2023-09-29 浙江国邦药业有限公司 一种l-脯氨酰胺中有关物质的hplc测试方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7030141B2 (en) * 2001-11-29 2006-04-18 Christopher Franklin Bigge Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
JP3975254B2 (ja) * 2002-07-25 2007-09-12 日野自動車株式会社 チャイルドシート用アンカの取付構造
DE10329457A1 (de) 2003-04-03 2005-01-20 Merck Patent Gmbh Ethinylprolinderivate
AU2004226278B2 (en) 2003-04-03 2010-07-29 Merck Patent Gmbh Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor Xa in the treatment of thrombo-embolic diseases
WO2004110433A1 (de) 2003-06-18 2004-12-23 Merck Patent Gmbh Pyrrolidin-1, 2- dicarbonsäure- 1- [(4- ethinyl- phenyl) - amid]- 2- [(phenyl)- amid] derivative als inhibitoren der koagulationsfaktoren xa und viia zur behandlung von thrombosen
ES2223277B1 (es) 2003-06-19 2006-03-01 Fernando Bouffard Fita Composicion anestesica para administracion topica.
DE10358814A1 (de) 2003-12-16 2005-07-21 Merck Patent Gmbh Prolinylarylacetamide
DE102004014945A1 (de) * 2004-03-26 2005-10-13 Merck Patent Gmbh Prolinylderivate
US7453002B2 (en) * 2004-06-15 2008-11-18 Bristol-Myers Squibb Company Five-membered heterocycles useful as serine protease inhibitors
DE102004045796A1 (de) 2004-09-22 2006-03-23 Merck Patent Gmbh Arzneimittel enthaltend Carbonylverbindungen sowie deren Verwendung
US20090099231A1 (en) 2005-04-11 2009-04-16 John David Harling 3-Sulfonylamino-Pyrrolidine-2-One Derivatives as Factor Xa Inhibitors
BRPI0613045A2 (pt) 2005-07-15 2010-12-14 Hoffmann La Roche aminas cÍclicas fundidas a heteroarila

Also Published As

Publication number Publication date
AU2007251614A1 (en) 2007-11-22
EA200802210A1 (ru) 2009-06-30
CA2653753C (en) 2013-09-24
PE20080702A1 (es) 2008-07-10
CL2007001391A1 (es) 2008-01-18
NZ573573A (en) 2011-10-28
CA2653753A1 (en) 2007-11-22
US7807693B2 (en) 2010-10-05
KR20090017523A (ko) 2009-02-18
DK2051975T3 (da) 2012-10-15
JP5263686B2 (ja) 2013-08-14
EP2051975B1 (de) 2012-09-12
NO20084530L (no) 2008-12-12
ES2395538T3 (es) 2013-02-13
IL195245A (en) 2012-09-24
PL2051975T3 (pl) 2013-01-31
US20080139605A1 (en) 2008-06-12
KR101422456B1 (ko) 2014-07-23
EP2051975A2 (de) 2009-04-29
AU2007251614B2 (en) 2013-01-17
JP2009537483A (ja) 2009-10-29
MY146623A (en) 2012-09-14
UY30352A1 (es) 2008-01-02
TW200813047A (en) 2008-03-16
BRPI0711648A2 (pt) 2011-11-29
ECSP088824A (es) 2008-11-27
IL195245A0 (en) 2009-09-22
WO2007131982A2 (de) 2007-11-22
MX2008014499A (es) 2008-11-27
AR060945A1 (es) 2008-07-23
WO2007131982A3 (de) 2008-01-10

Similar Documents

Publication Publication Date Title
HK1131140A1 (en) Substituted prolinamides, and the use thereof
IL206127A0 (en) Azolylmethyloxiranes, use thereof and agents containing the same
SI2217578T1 (sl) (1,2,4)triazolo(1,5-a)piridinske in (1,2,4)triazolo(1,5-c)pirimidinske spojine in njihova uporaba
EP2153838A4 (en) ANTI-NOROVIRUS AGENT AND COMPOSITION COMPRISING SAME
EP2209394A4 (en) Armtasche
ZA200902189B (en) Phenylpropionamide compounds and the use thereof
HK1130489A1 (en) Substituted-quinoxaline-type-piperidine compounds and the uses thereof
IL202073A0 (en) Substituted oxazolidinones and the use thereof
GB0616111D0 (en) Agents, methods and uses
EP1962635A4 (en) LOAD REDUCTION FOR SHOULDER AND USE THEREOF
GB0601471D0 (en) The cardioprotector
GB0520176D0 (en) Use
GB0511190D0 (en) Use
GB0502250D0 (en) Use
GB0502992D0 (en) The ballcaster
EP2192122A4 (en) Dithiolopyrrolone compounds and their preparation and use
GB0526032D0 (en) Use
GB0526031D0 (en) Use
IL194972A0 (en) 2-alkoxy-3,4,5-trihydroxy-alkylamide-
GB0608797D0 (en) Novel agents and the use thereof
ZA200805851B (en) Stress-reducer for shoulder and the use thereof
GB0602141D0 (en) The turboramjet
GB0511610D0 (en) The motor-roll-off
GB0612279D0 (en) The sockball
GB0604276D0 (en) The t-stick

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180514